标题
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
作者
关键词
-
出版物
INTENSIVE CARE MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-11
DOI
10.1007/s00134-020-06141-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching
- (2020) Rachel G. Scheraga et al. JOURNAL OF IMMUNOLOGY
- On the use of corticosteroids for 2019-nCoV pneumonia
- (2020) Lianhan Shang et al. LANCET
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
- (2020) Jesús Villar et al. Lancet Respiratory Medicine
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Human Umbilical Cord-Derived Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome
- (2020) Hon-Kan Yip et al. CRITICAL CARE MEDICINE
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
- (2020) Dan Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- TRPV4—A Missing Link Between Mechanosensation and Immunity
- (2020) Laura Michalick et al. Frontiers in Immunology
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Inhibition of SARS-CoV-2 by type I and type III interferons
- (2020) Ulrike Felgenhauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Early safety indicators of COVID-19 convalescent plasma in 5000 patients
- (2020) Michael J. Joyner et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
- (2020) Nicola Veronese et al. Frontiers in Medicine
- Streptokinase versus Unfractionated Heparin Nebulization in Patients with Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial with Observational Controls
- (2019) Ahmed Abdelaal Ahmed Mahmoud et al. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
- Population enrichment for critical care trials
- (2019) Manu Shankar-Hari et al. Current Opinion in Critical Care
- Alpha 1-antitrypsin for treating ventilator-associated lung injury in acute respiratory distress syndrome rats
- (2019) Xueting Wang et al. EXPERIMENTAL LUNG RESEARCH
- Inhibition of the Receptor for Advanced Glycation End-Products in Acute Respiratory Distress Syndrome: A Randomised Laboratory Trial in Piglets
- (2019) Jules Audard et al. Scientific Reports
- Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure
- (2019) Alpha A. Fowler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-IFN-γ therapy alleviates acute lung injury induced by severe influenza A (H1N1) pdm09 infection in mice
- (2019) Bo Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial
- (2019) Jean-Michel Constantin et al. Lancet Respiratory Medicine
- Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats
- (2019) Marta Camprubí‐Rimblas et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Yi Li et al. MOLECULAR IMMUNOLOGY
- Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injury
- (2018) Alastair Proudfoot et al. THORAX
- Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study
- (2018) Matthieu Jabaudon et al. Scientific Reports
- Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
- (2018) Carolyn S Calfee et al. Lancet Respiratory Medicine
- Negative trials in critical care: why most research is probably wrong
- (2018) John G Laffey et al. Lancet Respiratory Medicine
- Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
- (2018) Michael A Matthay et al. Lancet Respiratory Medicine
- Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease
- (2017) Asami Masui-Ito et al. MEDICINE
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Plasma Neutrophil Elastase and Elafin as Prognostic Biomarker for Acute Respiratory Distress Syndrome
- (2017) Tiehua Wang et al. SHOCK
- Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis
- (2017) L D Bos et al. THORAX
- The Role of Transient Receptor Potential Vanilloid 4 in Pulmonary Inflammatory Diseases
- (2017) Rachel G. Scheraga et al. Frontiers in Immunology
- RAGE inhibition reduces acute lung injury in mice
- (2017) Raiko Blondonnet et al. Scientific Reports
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
- (2016) Giacomo Bellani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefit of Tocilizumab Therapy for Adult-Onset Still Disease Complicated With Acute Respiratory Distress Syndrome
- (2016) Carolina Diez Morrondo et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury
- (2015) Alicia N. Rizzo et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
- (2015) Jason D. Christie et al. CRITICAL CARE MEDICINE
- A Functional Variant of Elafin With Improved Anti-inflammatory Activity for Pulmonary Inflammation
- (2015) Donna M Small et al. MOLECULAR THERAPY
- Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat
- (2015) J. Devaney et al. THORAX
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
- (2015) Jennifer G Wilson et al. Lancet Respiratory Medicine
- TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury
- (2014) Shrilatha Balakrishna et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- TRPV4: an exciting new target to promote alveolocapillary barrier function
- (2014) Rory E. Morty et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Anti-Inflammatory Effect of Thalidomide on H1N1 Influenza Virus-Induced Pulmonary Injury in Mice
- (2014) Haiyan Zhu et al. INFLAMMATION
- Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
- (2014) J. J. Grailer et al. JOURNAL OF IMMUNOLOGY
- Hyperimmune IV Immunoglobulin Treatment
- (2013) Ivan F.N. Hung et al. CHEST
- Angiotensin-(1–7) Protects From Experimental Acute Lung Injury
- (2013) Nadine Klein et al. CRITICAL CARE MEDICINE
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
- (2013) Hisham Momattin et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats
- (2012) Hans G. Folkesson et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
- (2012) Yiwu Yan et al. CELL RESEARCH
- Proteolytic cleavage of elafin by 20S proteasome may contribute to inflammation in acute lung injury
- (2012) Aoife Kerrin et al. THORAX
- A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome
- (2012) Peter E Morris et al. BMC Pulmonary Medicine
- TRPV4 channels augment macrophage activation and ventilator-induced lung injury
- (2010) Kazutoshi Hamanaka et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Thalidomide treatment modulates macrophage pro-inflammatory function and cytokine levels in Klebsiella pneumoniae B5055 induced pneumonia in BALB/c mice
- (2010) Vijay Kumar et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome
- (2009) Julie A. Bastarache et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Protective effects of adenosine A2A receptor agonist in ventilator-induced lung injury in rats
- (2009) Chin-Ming Chen et al. CRITICAL CARE MEDICINE
- Genetic Delivery of Bevacizumab to Suppress Vascular Endothelial Growth Factor-Induced High-Permeability Pulmonary Edema
- (2009) Masaki Watanabe et al. HUMAN GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started